HILLIARD, Ohio, May 07, 2026 (GLOBE NEWSWIRE) -- Command Alkon, the global leader in software and technology solutions for the heavy building materials industry, is among the winners of the 2026 World ...

TL;DR: ChatPlayground AI lets you compare multiple AI models side by side with unlimited access—all for a one-time $74.97 (MSRP $619). The old way of using AI involves bouncing between tabs, ...

A security researcher, working with colleagues at Johns Hopkins University, opened a GitHub pull request, typed a malicious instruction into the PR title, and watched Anthropic’s Claude Code Security ...

Many people are turning to artificial intelligence for personal finance advice. Writing a good AI prompt can mean the difference between receiving a reasonable or poor output, experts said. While AI ...

Adobe today launched its most ambitious AI offensive to date, unveiling the Firefly AI Assistant — a new agentic creative tool that can orchestrate complex, multi-step workflows across the company's ...

SNC’s site for E-4C work in Dayton, Ohio, has rapidly grown since the company won the competition in 2024. Credit: SNC The future backbone of U.S. nuclear command and control is taking shape in a set ...

Google on Thursday added new features to its video editor app Vids, including directing and customizing avatars through text prompts, Veo 3.1 support, the ability to export videos to YouTube, and ...

Something to look forward to: Microsoft released new Windows 11 Insider Preview builds to the Canary, Dev, and Beta channels this week, bringing multiple new features for developers and power users.

CNN correspondents and crew members were forced to run for cover in two separate incidents in Israel and Iran due to bombardments overhead. Anchor Erin Burnett and Jerusalem correspondent Jeremy ...

The Army will kick off its new retention bonus system next month, using physical fitness scores, technical expertise and commander evaluations to determine a soldier’s payout to reenlist. “We were ...

Two new cancer cases have prompted Kyowa Kirin to shutter all clinical studies of its investigational anti-OX40 monoclonal antibody designed to treat inflammatory diseases. The discontinuation will ...